News And Events

July 21 – 24, 2026 (Boston)

Gliomic Presents Initial Data at AACR Drug Discovery And Development Conference (AACRD3)

July 21 – 24, 2026 (Boston)  https://www.aacr.org/

Diana Shi, MD of Massachusetts General Hospital and the Dana Farber Institute, was one of 7 researchers selected among over 200 submissions to present during the Spotlight on Proffered Papers Session on July 22. Her talk, entitled “GLIO-1 is a selective DHODH inhibitor that is effective in IDH mutant gliomas and KDM6-mutated cancers,” was the first public presentation of Gliomic data in a scientific session. A copy of here presentation is enclosed here